Neftaly Case Studies: Biobanking Quality Failures

Biobanks play a pivotal role in supporting biomedical research, diagnostics, and personalized medicine by providing high-quality biospecimens. However, lapses in biobanking quality management can jeopardize sample integrity, compromise research outcomes, and lead to costly regulatory repercussions.

At Neftaly, we have partnered with biobanks worldwide to identify, analyze, and resolve quality failures. The following case studies illustrate common challenges and how Neftaly’s expertise has helped restore quality and compliance.

---

Case Study 1: Sample Degradation Due to Inadequate Storage Monitoring

Client: Academic biobank storing tissue and blood samples for cancer research
Issue: Elevated sample rejection rates due to repeated temperature excursions in ultra-low freezers, undetected for extended periods
Neftaly Solution:

• Installed automated temperature monitoring and alert systems with remote access
• Developed SOPs for freezer maintenance and emergency response
• Trained staff on critical storage condition management and corrective actions

Outcome:

• Drastically reduced temperature excursions by 90%
• Improved sample viability and reduced re-collection costs
• Enhanced audit readiness with full temperature logs and documentation

---

Case Study 2: Incomplete Documentation and Chain of Custody Breakdowns

Client: Commercial biobank providing samples to pharmaceutical companies
Issue: Frequent audit findings related to missing consent forms and inconsistent sample tracking records
Neftaly Solution:

• Implemented an integrated LIMS with barcode-based tracking and electronic consent management
• Standardized documentation workflows and introduced mandatory checklist reviews
• Conducted compliance training focused on ethical and legal requirements

Outcome:

• Achieved 100% compliance with donor consent documentation
• Eliminated sample misidentification and loss incidents
• Gained positive audit reports from regulatory authorities and clients

---

Case Study 3: Cross-Contamination During Sample Processing

Client: Hospital-based biobank processing diverse biospecimens for multiple research projects
Issue: Contamination detected in DNA samples affecting downstream genomic analyses
Neftaly Solution:

• Performed root cause analysis identifying procedural lapses and equipment contamination
• Redesigned workflows to include dedicated processing areas and single-use consumables
• Enhanced cleaning protocols and implemented environmental monitoring

Outcome:

• Eliminated contamination incidents in subsequent batches
• Improved confidence in sample quality among research partners
• Instituted continuous quality control checks to prevent recurrence

---

Case Study 4: Regulatory Noncompliance Leading to Temporary Suspension

Client: National biobank supporting COVID-19 vaccine research
Issue: Regulatory body imposed a temporary suspension due to inadequate staff training and poor SOP adherence
Neftaly Solution:

• Delivered targeted staff training and competency assessments
• Updated and enforced SOPs aligned with ISO 20387 standards
• Supported re-inspection preparation and corrective action reporting

Outcome:

• Suspension lifted within 3 months
• Established a sustainable quality culture and ongoing compliance monitoring
• Increased stakeholder confidence and donor participation

---

Conclusion

Biobanking quality failures can have far-reaching consequences for scientific progress and patient outcomes. Neftaly’s comprehensive quality management expertise enables biobanks to identify vulnerabilities, implement effective corrective actions, and build resilient systems for long-term success.